beta-amyloid 40 (Aβ40) antibody and antigen (Recombinant protein)

Diagnostic beta-amyloid 40 (Aβ40) antibodies (anti-beta-amyloid 40, anti-Aβ40) and antigens (recombinant beta-amyloid 40 (Aβ40) protein) for Neurodegenerative diseases Aβ40 detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Target products collectionGo to Neurodegenerative diseases diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-h-Aβ40-Ag01 Beta-amyloid 40 (Aβ40) antigen $3090.00
GMP-h-Aβ40-Ab01 Anti-human Aβ40 mouse monoclonal antibody (mAb) $1953.00
GMP-h-Aβ40-Ab02 Anti-human Aβ40 mouse monoclonal antibody (mAb) $1953.00
GMP-h-Aβ40-Ab03 Anti-human Aβ40 human monoclonal antibody (mAb) $1953.00
GMP-h-Aβ40-Ab04 Anti-human Aβ40 human monoclonal antibody (mAb) $1953.00

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Pruducts GMP-h-Aβ40-Ag01
Product Name Beta-amyloid 40 (Aβ40) antigen
Target/Biomarker beta-amyloid 40 (Aβ40)
Alias of Target/Biomarker AAA, ABETA, ABPP, AD1I, CTFgamma, CVAP, PN-II, PN2, alpha-sAPP, preA4, APP
Expression platform synthesized
Isotypes NA
Bioactivity validation beta-amyloid 40 (Aβ40) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Aβ40 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation
Products description Beta-amyloid 40 (Aβ40) antigen is synthesized
Purity Purity: ≥95% (HPLC)
Application positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Pruducts GMP-h-Aβ40-Ab01,GMP-h-Aβ40-Ab02
Product Name Anti-human Aβ40 mouse monoclonal antibody (mAb)
Target/Biomarker beta-amyloid 40 (Aβ40)
Alias of Target/Biomarker AAA, ABETA, ABPP, AD1I, CTFgamma, CVAP, PN-II, PN2, alpha-sAPP, preA4, APP
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Human beta-amyloid 40 (Aβ40) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other beta-amyloid 40 (Aβ40) antibodies in Aβ40 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation.
Tag mFc
Products description Anti-human Aβ40 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other beta-amyloid 40 (Aβ40) antibodies.
Reconized/Reactive Species Human
Purity Purity: ≥95% (SDS-PAGE)
Application ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No. of Pruducts GMP-h-Aβ40-Ab03,GMP-h-Aβ40-Ab04
Product Name Anti-human Aβ40 human monoclonal antibody (mAb)
Target/Biomarker beta-amyloid 40 (Aβ40)
Alias of Target/Biomarker AAA, ABETA, ABPP, AD1I, CTFgamma, CVAP, PN-II, PN2, alpha-sAPP, preA4, APP
Expression platform CHO
Isotypes Human lgG1
Bioactivity validation Human beta-amyloid 40 (Aβ40) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other beta-amyloid 40 (Aβ40) antibodies in Aβ40 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation.
Tag hFc
Products description Anti-human Aβ40 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Reconized/Reactive Species Human
Purity Purity: ≥95% (SDS-PAGE)
Application ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    Easily accessible biomarkers are needed for the early identification of individuals at risk of developing Alzheimer's disease (AD) in large population screening strategies. Low plasma Aβ42/40 was associated with more pronounced decline in cognitive function (measured by multiple outcomes) over time. Findings suggest that plasma Aβ42/40 may be used to identify people at risk of cognitive decline, being an alternative to more complex and expensive measures, such as positron emission tomography imaging or cerebrospinal fluid measurement.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    No comments yet.

    Leave a comment